Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in Microsoft Word file (.doc or .docx format).
  • Where available, URLs for the references have been provided.
  • The text is double-spaced; uses a 12-point Times New Roman font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Journal of Brain and Spine foundation Nepal (JBSFN) receives original material of interest to the practitioners and scientists in Neurosurgery, Neurology and spine related disorder as well as materials from other allied specialties with association to Neurosurgery, Neurology and Spine e.g. Neuropsychiatry, Neuro-ophthalmology, Neuro-otorhinolaryngology etc. The manuscripts should be original, not published or considered for publication elsewhere and author should select the type of article during the submission; however, editorial board will decide the category under which the article will be published.

All Manuscript should be accompanied with following supporting documents which can be downloaded from the following link:

Authors are supposed to send their completed manuscript along with the supporting documents to We request authors to go through the guidelines and stick to it for preparation of their manuscripts. Manuscript not submitted according to instructions will be returned back to the author for correction before beginning the peer review process. JBSFN follows a double blinded peer review policy. Please Mention the author’s details in the title page and try not disclose any sort of identity in the manuscript to ensure double blinded peer review.

General Requirements

  • Manuscript should be submitted in Microsoft word file (.doc or .docx format)
  • Manuscript should be written in British English
  • Manuscript should be prepared in A4 size with margins of 1.5 inches all over the page, double spaced and typed in Times New Roman font of 12 point.
  • Each section has to be on separate page and in following order: Title page without author’s identity including abstract and keywords, introduction, methods, results, discussion, acknowledgements, references, tables, figures and legends.
  • Number each page consecutively beginning with title page at upper right- hand corner of each page.
  • Abbreviations:
    • Avoid using abbreviations in abstract. Abbreviations should be written in brackets along with its full form when used for the first time.
    • Universal abbreviations do not need a full form however, for example; HIV, WHO, e.g., etc.
    • Do not use ‘&’ and ‘@’ in the text. Please do not write in contractions. For e.g. write “do not” instead of “don’t”.
  • Numbers and Units
    • Words not number should commence a sentence e.g. “Eighty one of cases were….”
    • Number less than 10 should be mentioned in words e.g. “seven patients…..”
    • Do not use space between number and its percentage sign. Write percentage to two decimal points.
    • Use SI units in the manuscript e.g. mmHg, o
  • Drugs should always be mentioned in generic form.

Components of Manuscript:

  • Title Page:
    • A concise and informative title stating about the subject of the article not exceeding 200 characters.
    • Full names of each author with highest academic degree, designation, affiliation, e-mail address and ORCID iD.
    • Full name with highest academic degree, designation, affiliation, e-mail address, contact number and ORCID iD of corresponding author.
    • Total word counts of abstract, manuscript (excluding abstract, keywords, tables and figures), number of references, number of tables and figures.
    • Short Running Title: Not exceeding 50 characters or 8 words.
    • Source of funding, support or grant and any conflict of interest.
  • Manuscript Page
    • Abstract with Keywords: A structured abstract giving a concise idea about the article to the readers should be submitted in a separate paper consisting of Introduction, Methods, Results and Conclusion. The abstract should not exceed 250 words. Abstracts should be followed by 3-6 ‘Key words’ in alphabetical order. Each Key word should be capitalized, separated by comma and not followed by full stop. Key words should be used as indexed in MeSH which can be checked from
    • Introduction: Introduction provides a brief context, background, the reason for undertaking the study and the effect the study imparts to the existing scientific literature.
    • Methods: This section should describe in details about planning of the study, study design, type of study, duration of study and the site of study. Sampling methods and sample size should be elaborately described. Inclusion and exclusion criteria, methods of data collection, statistical tools and software used should be described in details. Materials used for studies should be clearly mentioned along with the manufacturer’s name and address. Similarly if any drug is used make sure to write the generic name as far as possible along with the dosage, frequency and route of administration. Whenever applicable ethical approval along with the approving authority (e.g. IRC) should be mentioned. Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting, and synthesizing data.
    • Results: Results should be clear and easy to understand. It should be in logical order, highlighting the main findings first without any interpretation of the data. Use a mixture of text, tables, and figures, but there shouldn’t be repetition of data. Use both number and percentage while representing data. Provide statistical analyses and its outcome.
    • Discussion: This is the most important section of the manuscript and thus, it should be very carefully constructed. While discussing, it should not merely be a repetition of results section but the objectives of the study should be addressed by the interpretation of results. Compare your results with previous works. Discuss the clinical and scientific (if any) implications of your findings and suggest further research. Whenever possible discuss about the limitations of the study to suggest for future research, the unanswered or unsolved issues and how these could have been overcome according to your perspective.
    • Conclusions: Conclusion should be linked with the title and objectives of the study. Do not make statements not adequately supported by your findings.
    • Acknowledgements: Those who have helped the authors carry out the study and/ or prepare the manuscript but have not made significant intellectual contribution to deserve authorship must be acknowledged. Mention all applicable grants and other funding that supported the work.
    • References: References should be typed double spaced at the end of the manuscript and numbered consecutively in the order in which they are cited in the text (not alphabetical). The journal follows Vancouver System for referencing and the style for referencing are based on the Citation Medicine formats used by U. S. National Library of Medicine (NLM) PubMed/Medline database. The name of journal should be abbreviated in accordance with Index Medicus. If the journal is not listed in Index Medicus then it should be written out in full. Avoid using abstracts and unpublished data as references. Include the last names and initials of the authors (multiple authors: list up to the first 6 authors followed by et al.), title of article, name of journal/publication, year published, volume number, Issue number, and inclusive pages. For help on reference style, read Maximum of 30 most relevant and latest as possible references are recommended. Please provide DOI (Digital Object Identifier) if they have one. Those who do not have both should contain web-link to the page containing that article. In order to generate the DOI just copy and paste your references arranged in order to the space provided-, you could get DOI in few minutes.
    • Citation: Only published or in press articles should be cited and included in the reference list. The references in the text should be identified by Arabic numerals as superscript after the punctuation mark (with no word spacing) and in order in which it is cited in the text. If you are citing more than one references, list each reference number separated by a comma, or by a dash for a sequence of consecutive numbers but do not give any space between commas or dashes.
    • Few References examples:
      • Journal Article:
      • Journal Article (more than 6 authors)
        • Hasan K, Bulhan K P, Zafar A, et al. Acute leukemia in children. French-American-British (FAB) classification and its relation to clinical features. J Pak Med Assoc 1992; 4:229-31.
      • Online Journal Article
        • Kanneganti P, Harris JD, Brophy RH, Carey JL, Lattermann C, Flanigan DC. The effect of smoking on ligament and cartilage surgery in the knee: a systematic review. Am J Sports Med [Internet]. 2012 Dec [cited 2013 Feb 19];40(12):2872-8. Available from:
      • Book and Book Chapter
        • Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.
        • Dupont B. Bone marrow transplantation in severe combined immunodeficiency with an unrelated MLC compatible donor. In: White H J Smith R, eds. Proceeding of the third annual meeting of the International Experimental Hematology. Houston: International Society for Experimental Hematology, 1974, pp 44-46.
      • In Press
        • Leshner AI. Molecular mechanisms of cocaine addiction. N EngI J Med. In press 1996.
      • Monograph in electronic form
        • CDI, clinical dermatology illustrated [monographs on CD-ROM] Reeves JRT, Maibach H. CMEA Multimedia group, producers 2nd ed. Version 2.0. San Diego: CMEA, 1995.
      • Conference proceedings
        • Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology, 1995 Oct 15-19, Kyoto, Japan. Amsterdam: Elsevier, 1996.
      • Volume with supplement
      • World Wide Web page
      • World Wide Web page (no author)
      • Tables/Figures
        • Tables should be typed in separate page and should be typed in double space. Tables should not be submitted as photographs or Excel files. Tables should be labeled at the top and numbered consecutively in the order of their first citation in the text. Each table should be supplied with a brief title. Any explanatory matter should be placed in footnotes and should be indicated by symbol (*,**). Tables should also contain statistical measure (for example, P values). If data from another published source are used, obtain written permission from the publisher of the original source and acknowledge fully. If data from an unpublished source are used, obtain permission from the principal investigator and acknowledge fully.
        • Figures should be drawn professionally with “low ink to data ratio” and without “3D” view and preferably in black and white. Color figures and pictures will be accepted as such for online version and if color figures are requested in print version as well, the author will be charged a fee to cover the cost of printing which will be decided by the publication house. Such figures must be submitted in JPEG files with a minimum resolution of 300 dpi (dots per inch). Figures should be large enough to read easily and convey only essential information. The preferred typeface in figures is 12-pt Times New Roman. Histogram should be submitted in a simple 2-D form with plain background. Photographs of persons should not be identifiable unless it is accompanied by written permission from the subject. Figures should be numbered consecutively in the order of their first citation in the text.

Types of Manuscripts accepted

  • Original Article: Randomized controlled trials, interventional studied, studies of screening and diagnostic test, outcome studies, cost effectiveness analyses, case-control series and surveys with high response rate. Up to 3500 words (excluding references of maximum 30 and abstract of maximum 250 words) are suggested for original articles.
  • Review Article: Systemic critical assessments of literature and data sources. Up to 3500 words (excluding references 30 and abstract 250 words) are suggested for review articles..
  • Case Report: The journal welcomes interesting case reports with clinical significance or implications. Total word cound allowed for case reports are 1500 words excluding references (up to 10) and abstract (up to 250 words). Use the CARE Case Report Checklist while preparing your case report.
  • Short Communication: These are short, peer-reviewed articles focusing on a high-quality, of original research and/or the proposal of a new theory of a new theory or concept based on existing research. They should not be preliminary reports or contain purely incremental data and should be of significance and broad interest to the field of medical sciences. Maximum 2000 words (excluding references of maximum 30 and abstract of maximum 250 words).
  • Viewpoint: These articles are personal views and allow you to express you own point of view on any issues relevant to health. We like these to include controversial subjects (maximum 800 words excluding reference up to 5-8).
  • Letter to the Editor: It is a short and unstructured article with opinions (including criticism) of articles published in JBSFN. Letter to the Editor will be accepted or edited and published at the Editor’s discretion. The author must refer to the article published in BSFN and address the major subjects he/she wants to comment on regarding the article. Letter to the editor should ideally be sent within four weeks of publication of the referred article. If the author’s response is deemed necessary by the editorial team, the authors shall be notified and response awaited within next fifteen days and both the letter and the author’s comment will be published in the next issue and the website. If no response is received from the author, the letter will be published with a note that author response was not received. The letter should not exceed 1000 words and 10 references.
  • Editorial: This is written in each issue by the editor or members of editorial board and is not open for external authors unless invited. It is usually unstructured and has no limits on words and references.

Plagiarism Policy: All manuscripts submitted to the Journal will be checked for plagiarism and if plagiarism is suspected in any published or on review articles, the authors will be sought for a suitable explanation. If the explanation is suitable as decided by the editorial board, the authors will be advised necessary changes before publication. However, if no explanation is received or an unsuitable explanation is received, the editorial board shall decide on a suitable action to be taken which may vary from withdrawal/rejection of the manuscript, debarment of further publication for varied duration according to the offence, a notice to the head of the institute regarding the offence and information regarding the same in upcoming issue.

Copyright: JBSFN is an open access journal and thus the articles are published in .pdf formats in its website which can be freely accessed. However, all the works are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows use, distribution, and reproduction in any medium, provided the original work is properly cited.

Page Proofs: After the acceptance of the manuscript, page proofs will be sent to the corresponding author. If any minor corrections are necessary, we expect the author to revert back to the editorial team with 72 hours.

Erratum/Correction: If authors of a published article subsequently become aware of a significant error in it, they should send a notifying letter to the editor of NJMS as soon as possible. If the mistake is judged significant enough to warrant a published correction, the correction will be made as an ‚erratum‛ if the fault is NJMS’s; ‚correction‛ if the fault is the author’s.

Authorship: The order, addition or deletion of author names will not be changed after submission of the article.

Processing Charge: There is no Processing charge for the journal.

Publication Charge: In order to cover the cost on publishing print as well as online editions, and the cost on distribution, JBSFN has decided to charge a minimal amount of 50 USD to foreign authors and NRS 3500 to Inland authors. The Publication fee is subject to change with time and also can be waived in special circumstances, the decision of which lies solely within the editorial board.

Peer Review Process

Articles are to be submitted to the journal via the official email These articles will then undergo primary review in the editorial office assigned to the members by the Chief or Managing Editor. The articles which fulfil the journal’s guidelines will be checked for plagiarism. Once all the preliminary steps are passed, the articles will be assigned to two peer reviewers who will be blinded about the articles’ authors and their place of study. The peer review will take about 4-6 weeks from the date of submission. The article shall be sent back to the corresponding author if any corrections or explanation is required. Once all corrections are made and resubmitted, the final review will be done by the editorial board (mainly the Chief Editor or the Managing Editor). Once the final decision has been made, the article will be sent for formatting and a pre-print soft copy shall be sent the corresponding author for proof-reading and license to publish the article and their consent shall be taken before sending the article for Print/publishing. The article shall be available both online (open access) and in a print version.

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called In using this plugin we are not collecting, controlling or processing the data. More details on the privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)